ACB $1.430 (1.42%)
ACNNF $0.030 (0%)
AERO $3.210 (0%)
ALEAF $0.050 (-14.97%)
AMMJ $0.048 (12.81%)
APHA $15.380 (0%)
ARNA $99.990 (0%)
ATT:CNX $0.080 (0%)
AUSA:CNX $0.065 (0%)
AUSAF $0.050 (0%)
AVXL $11.060 (-0.98%)
BAMM:CNX $0.130 (0%)
BBM:CNX $0.030 (-14.29%)
BBRRF $0.027 (-3.27%)
BE:CNX $0.005 (0%)
BIO:CNX $0.013 (0%)
BLIS:CNX $0.315 (0%)
BLO:CNX $0.395 (2.6%)
BLOZF $0.308 (2.5%)
BUDZ $0.100 (-9.09%)
CADMF $0.052 (0%)
CALI:CNX $0.085 (13.33%)
CANN $0.230 (-2.13%)
CARA $9.060 (-6.69%)
CBWTF $0.062 (0.16%)
CGC $2.540 (-0.97%)
CGRW $0.016 (-22%)
CHOO:CNX $0.005 (0%)
CHOOF $0.003 (-16%)
CNBX $3.990 (0%)
CNGGF $0.203 (0%)
CODI $22.680 (0.22%)
CPMD $0.020 (-4.81%)
CRBP $0.281 (0.07%)
CRON $3.050 (0.33%)
CROP:CNX $0.015 (0%)
CSI:CNX $0.070 (-12.5%)
CURR $0.349 (2.65%)
CVSI $0.033 (7.49%)
DIGP $0.014 (0%)
EEVVF $0.078 (0%)
EMHTF $0.039 (10.17%)
EPWCF $0.059 (0%)
FFT:CNX $0.040 (0%)
FNNZF $0.075 (13.64%)
GNBT $0.001 (0%)
GRIN:CNX $0.075 (-16.67%)
GRWG $4.840 (-1.83%)
GTBIF $10.150 (-1.46%)
GTII:CNX $13.090 (-1.65%)
GWPH $218.960 (0%)
HEXO $0.196 (-0.56%)
HHPHF $0.079 (0%)
HLSPY $0.363 (0%)
HMLSF $2.800 (0%)
HMPPF $0.498 (0%)
HRVOF $0.023 (-11.07%)
HSTRF $0.135 (0%)
HUGE:CNX $1.180 (-1.67%)
IAN:CNX $0.075 (0%)
IGC $0.520 (-3.02%)
IGXT $0.219 (13.76%)
IIPR $92.910 (-2.5%)
INQD $0.009 (-3.23%)
IONC:CNX $0.005 (0%)
IONKF $0.005 (-2.04%)
ISOL:CNX $0.035 (0%)
ITHUF $0.062 (5.65%)
KBEV:CNX $0.045 (0%)
KHRNF $0.091 (-2.15%)
KSHB $0.695 (0%)
LHS:CNX $1.470 (0%)
LHSIF $1.145 (0%)
LXX:CNX $8.400 (0%)
MCIG $0.028 (0%)
MEDIF $0.057 (1.15%)
MGWFF $0.060 (9.57%)
MJ:CNX $0.050 (0%)
MJNA $0.015 (1.4%)
MNTR $0.040 (0%)
MYM:CNX $0.140 (0%)
MYMMF $0.106 (0%)
NCNNF $0.058 (0%)
NDVAF $0.111 (-6.17%)
NGW:CNX $0.410 (0%)
NRXCF $0.035 (0%)
NSPDF $0.010 (-23.53%)
NVTQF $0.596 (0%)
NWKRF $0.424 (0%)
NXGWF $0.316 (0%)
NXTTF $0.033 (6.61%)
OH:CNX $5.330 (0%)
ORHOF $4.050 (0%)
PHCG $0.001 (0%)
PHVAF $0.038 (0%)
PILL:CNX $0.230 (-17.86%)
PKG:CNX $0.020 (-20%)
PLPRF $0.357 (0%)
PLUS:CNX $0.440 (0%)
PMCB $2.420 (0%)
PNPL $0.012 (0%)
PTNYF $0.018 (3.24%)
QCA:CNX $0.095 (-5%)
RDDTF $0.020 (1.53%)
RLLVF $0.001 (0%)
RMHB $0.028 (2.8%)
RQB:CNX $0.005 (0%)
RQHTF $0.448 (2.99%)
SLNG:CNX $0.095 (-9.52%)
SMG $83.180 (-1.21%)
SNN:CNX $0.155 (0%)
SOL:CNX $0.320 (0%)
SOLCF $0.250 (0%)
SPLIF $0.016 (-15.79%)
SPRWF $0.268 (0%)
STEM:CNX $0.035 (0%)
STMH $0.028 (1.45%)
SUN:CNX $0.150 (0%)
TBPMF $0.052 (3.82%)
TCAN:CNX $0.135 (0%)
TCNAF $0.080 (0%)
TER:CNX $3.480 (-0.57%)
TGEN $1.200 (0%)
TGIF:CNX $0.025 (-16.67%)
TGIFF $0.020 (-12.28%)
THC:CNX $0.048 (0%)
THCBF $0.044 (12.85%)
TLRY $3.540 (1.14%)
TRLFF $0.035 (0%)
TRSSF $2.710 (0.37%)
TURV $0.001 (0%)
VIDA:CNX $0.055 (0%)
VIN:CNX $0.015 (0%)
VPRB $0.047 (-6%)
VRTHF $0.026 (0%)
VVCIF $0.035 (-8.14%)
WAYL:CNX $0.740 (0%)
XXII $1.740 (-12.12%)
ZDPY $0.740 (-2.63%)
ZYNE $1.190 (-0.83%)
TORONTO, Jan. 9, 2023 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), continues to pioneer the medical cannabis market in LATAM by announcing that Zerenia has signed a contract with insurance CAPITAL SALUD EPS, to provide medical cannabis services and products to CAPITAL SALUD EPS…
Last week, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) reported strong first quarter financial results and announced several new company records. From the number of prescriptions filled to the amount of revenue generated, Khiron’s first quarter financial results showed impressive growth on several key metrics and our…
A few weeks ago, Khiron published fourth quarter financial results and we are favorable on how the business is positioned to record strong growth on a going forward basis. Reports Ramping Revenues While Cutting Expenses During the quarter, Khiron reported that revenues grew more than 30% on a quarter-over-quarter basis…
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced today its financial results for the year ended and quarter ended December 31, 2020. These filings are available for review on the Company's SEDAR profile at www.sedar.com. All financial…
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe , is pleased to announce that the Company has successfully delivered EU-GMP medical cannabis product to Germany . In collaboration with Nimbus Health, a leading…